Personalized Antidepressant Treatment Reduced Discontinuation In Major Depressive Disorder (17% vs. 27%)

People with major depressive disorder (MDD) who received a personalized antidepressant selected using a web-based clinical decision-support system were less likely to discontinue treatment within eight weeks. The discontinuation rate was 17% for those who received a personalized antidepressant prescription compared to 27% for those who received usual care. Discontinuation rates within eight weeks due to adverse effects were 9% among those who received personalized prescribing and 16% among the usual care group.

After 24 weeks, scores on the Patient Health Questionnaire-9 (PHQ-9) averaged 7.1 for the personalized prescribing group and 9.2 for the . . .